| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000236772.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.003323698 |
Resistant |
| ENSG00000236772.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.043488846 |
Resistant |
| ENSG00000236772.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.013452717 |
Resistant |
